| __timestamp | ACADIA Pharmaceuticals Inc. | Axsome Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 4279200 |
| Thursday, January 1, 2015 | 73869000 | 6776987 |
| Friday, January 1, 2016 | 99284000 | 21199860 |
| Sunday, January 1, 2017 | 149189000 | 19957616 |
| Monday, January 1, 2018 | 187163000 | 23495055 |
| Tuesday, January 1, 2019 | 240385000 | 53647067 |
| Wednesday, January 1, 2020 | 319130000 | 70244579 |
| Friday, January 1, 2021 | 239415000 | 58060725 |
| Saturday, January 1, 2022 | 361575000 | 57947447 |
| Sunday, January 1, 2023 | 351619000 | 97944000 |
| Monday, January 1, 2024 | 187077000 |
Cracking the code
In the competitive world of biopharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, ACADIA Pharmaceuticals Inc. and Axsome Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, ACADIA Pharmaceuticals consistently outpaced Axsome Therapeutics in R&D spending, with a peak in 2022 where their budget was nearly 3.7 times that of Axsome. Notably, ACADIA's R&D expenses surged by approximately 500% from 2014 to 2022, reflecting their aggressive pursuit of new therapies. In contrast, Axsome's R&D budget grew by over 2,000% during the same period, indicating a rapid scale-up in their research efforts.
These trends highlight the dynamic nature of the biopharmaceutical industry, where strategic R&D investments can drive innovation and potentially lead to groundbreaking treatments.
R&D Spending Showdown: Novartis AG vs ACADIA Pharmaceuticals Inc.
Amgen Inc. or ACADIA Pharmaceuticals Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Axsome Therapeutics, Inc.
Gilead Sciences, Inc. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Regeneron Pharmaceuticals, Inc. and ACADIA Pharmaceuticals Inc.
R&D Spending Showdown: Genmab A/S vs Axsome Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Analyzing R&D Budgets: Ionis Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Research and Development Investment: Axsome Therapeutics, Inc. vs Alpine Immune Sciences, Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
ACADIA Pharmaceuticals Inc. vs Galapagos NV: Strategic Focus on R&D Spending